Review
Bone Marrow Transplantation (2008) 41, 495–503; doi:10.1038/sj.bmt.1705888; published online 22 October 2007
Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant
- 1Section of Haemato-Oncology, Royal Marsden Hospital, Surrey, UK
- 2Anthony Nolan Research Institute, London, UK
- 3Department of Haematology, Nottingham University Hospitals, Nottingham, UK
Correspondence: Dr BE Shaw, Blood and Marrow Transplantation, Institute of Cancer Research/Royal Marsden Hospital, Brookes Lawley Building, 15 Cotswold Road, Belmont, Sutton, Surrey SM2 5NG, UK. E-mail: bshaw@doctors.org.uk
Received 13 June 2007; Revised 20 August 2007; Accepted 13 September 2007; Published online 22 October 2007.
Abstract
The management of acute leukaemia which relapses following an allogeneic stem cell transplant remains a major challenge. In this review we summarize the outcomes of the currently available treatment modalities and discuss emerging novel approaches.
Keywords:
haematopoietic cell transplantation, acute leukaemia, relapse, GvL, donor leucocyte infusions
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML
Bone Marrow Transplantation Review
RESEARCH
Journal of Cerebral Blood Flow & Metabolism Original Article
Bone Marrow Transplantation Original Article
Graft-versus-tumour effect in refractory metastatic neuroblastoma
Bone Marrow Transplantation Letter
Bone Marrow Transplantation Original Article

